Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers

Quality of Life Research

Volumn 19, Issue 2, 2010, Pages 177-189

  Lauzier, Sophie ^a,b   Maunsell, Elizabeth ^a,c   Drolet, Mélanie ^a   Coyle, Douglas ^d   Hébert Croteau, Nicole ^e  

^a LAVAL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

Breast cancer; Cost of illness; Methods; Out of pocket costs; Validity; Wage losses

Indexed keywords

ALGORITHM; ARTICLE; BREAST TUMOR; CANADA; CAREGIVER; COST; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; INFORMATION DISSEMINATION; INFORMATION PROCESSING; METHODOLOGY; PATIENT SATISFACTION; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; STANDARD; STATISTICS; VALIDATION STUDY; WOMEN'S HEALTH;

ALGORITHMS; BREAST NEOPLASMS; CAREGIVERS; DEDUCTIBLES AND COINSURANCE; FEMALE; FOCUS GROUPS; HEALTH CARE COSTS; HUMANS; INFORMATION DISSEMINATION; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUEBEC; QUESTIONNAIRES; WOMEN'S HEALTH;

EID: 77952544270     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-009-9575-y     Document Type: Article

References (53)

1. Hillner, B. (1996). Economic and cost-effectiveness issues in breast cancer treatment. Seminars in Oncology, 23(1 (suppl 2)), 98-104.
2. Pass, C., Lowes, B., & Davies, L. (1993). Collins dictionary of economics. London: Collins.
3. Collins, D. J., & Lapsey, H. M. (1991). Estimating the economic costs of drug abuse in Australia. National Campaign Against Drug Abuse Monograph Series, 15.
4. Koopmanschap, M. A., Rutten, F. F. H., & Van der Maas, P. (1993). Indirect costs in economic studies. PharmacoEconomics, 4, 1-9.
5. Carmines, E., & Zeller, R. (1979). Reliability and validity assessment. Newbury Park: Sage.
6. Aday, L. A. (1996). Designing and conducting health surveys: A comprehensive guide (2nd ed.). San Francisco: Jossey-Bass.
7. Agency for Healthcare Research and Quality (AHRQ). (2001). Medical Expenditure Panel Survey Medical Expenditure Panel Survey [questionnaire]. http://www.meps.ahrq.gov/whatis.htm. Accessed June 17, 2009.
8. Birenbaum, L. K., & Clarke-Steffen, L. (1992). Terminal care costs in childhood cancer. Pediatric Nursing, 18(3), 285-288.
9. Given, B. A., Given, C. W., & Stommel, M. (1994). Family and out-of-pocket costs for women with breast cancer. Cancer Practice, 2(3), 187-193.
10. Houts, P. S., Harvey, H. A., Simmonds, M. A., Marshall, M., Gottleib, R., Lipton, A., et al. (1985). Characteristics of patients at risk for financial burden because of cancer and its treatment. Journal Psychosocial Oncology, 3(2), 15-22.
11. Houts, P. S., Lipton, A., Harvey, H. A., Martin, B., Simmonds, M. A., Dixon, R. H., et al. (1984). Nonmedical costs to patients and their families associated with outpatient chemotherapy. Cancer, 53, 2388-2392.
12. Houts, P. S., Lipton, A., Harvey, H. A., & Martin, B. A. (1983). A method for collecting detailed data on direct and indirect medical expenses of cancer patients. Progress in Clinical and Biological Research, 120, 193-199.
13. Lansky, S. B., Cairns, N. U., Clark, G. M., Lowman, J., Miller, L., & Trueworthy, R. (1979). Childhood cancer: Nonmedical costs of the illness. Cancer, 43(1), 403-408.
14. Moore, K. A. (1999). Breast cancer patients' out-of-pocket expenses. Cancer Nursing, 22(5), 389-396.
15. Barr, R. D., Furlong, W., Horsman, J. R., Feeny, D., Torrance, G. W., & Weitzman, S. (1996). The monetary costs of childhood cancer to the families of patients. International Journal of Oncology, 8, 933-940.
16. Bloom, B. S., Knorr, R. S., & Evans, A. E. (1985). The epidemiology of disease expenses. The costs of caring for children with cancer. Journal of the American Medical Association, 253(16), 2393-2397.
17. Bodkin, C. M., Pigott, T. J., & Mann, J. R. (1982). Financial burden of childhood cancer. British Medical Journal, 284(6328), 1542-1544.
18. Monaco, G. P. (1983). Economics as a significant contributor to family stress in childhood cancer. Progress in Clinical and Biological Research, 132E, 387-394.
19. Stommel, M., Given, C. W., & Given, B. A. (1993). The cost of cancer home care to families. Cancer, 71(5), 1867-1874.
20. Willis, G. B. (1999). Cognitive Interviewing. A "How to" Guide. Meeting of the American Statistical Association.
21. Lauzier, S., Maunsell, E., De Koninck, M., Drolet, M., Hebert-Croteau, N., & Robert, J. (2005). Conceptualization and sources of costs from breast cancer: Findings from patient and caregiver focus groups. Psycho-Oncology, 14(5), 351-360.
22. Frey, J., & Fontana, A. (1993). The group interview in social research. In D. Morgan (Ed.), Successful focus groups: Advancing the state of the art (pp. 20-34). Newbury Park: Sage.
23. Kitzinger, J. (1995). Introducing focus groups. British Medical Journal, 311, 299-302.
24. Morgan, D. L. (1998). Focus group as qualitative research. Newbury Park: Sage.
25. Wolff, B., Knodel, J., & Sittitrai, W. (1993). Focus groups and surveys as complementary research methods: A case example. In D. Morgan (Ed.), Successful focus groups advancing the state of the art (pp. 118-136). Newbury Park: Sage.
26. Drolet, M., Maunsell, E., & Lauzier, S. (2001). Family costs of breast cancer: Extent, determinants and relation with quality of life. Progress report to the Canadian Breast Cancer Research Alliance (CBCRA). September 1999-August 2001.
27. Cancer Care Inc. (1973). The impact, costs, and consequences of catastrophic illness on patients and families. A report of a social research study of selected families stricken by advanced cancer. New York: Cancer Care, Inc. and The National Cancer Foundation, Inc.
28. Maguire, P., Pentol, A., Allen, D., Tait, A., Brooke, M., & Sellwood, R. (1982). Cost of counselling women who undergo mastectomy. British Medical Journal, 284, 1933-1935.
29. Drolet, M., Maunsell, E., Mondor, M., Brisson, J., Brisson, C., Mâsse, B., et al. (2005). Work absence after breast cancer diagnosis: A population-based study. Canadian Medical Association Journal, 173(7), 765-769. (Pubitemid 41428512)
30. Maunsell, E., Drolet, M., Ouhoummane, N., & Robert, J. (2005). Breast cancer survivors accurately reported key treatment and prognostic characteristics. Journal of Clinical Epidemiology, 58(4), 364-369.
31. Drummond, M., Sculpher, M., Torrance, G., O'Brien, B., & Stoddart, G. (2005). Economic evaluation using patient-level data. In M. Drummond, M. Sculpher, G. Torrance, B. O'Brien, & G. Stoddart (Eds.), Methods for the economic evaluation of health care programmes (3rd ed., pp. 247-275). Oxford: Oxford University Press.
32. Microsoft. (2001). Streets and Trips software.
33. Lauzier, S., Maunsell, E., Drolet, M., Coyle, D., Hébert-Croteau, N., Brisson, J., et al. (2008). Wage losses in the year after breast cancer: Extent and determinants among Canadian women. Journal of the National Cancer Institute, 100(5), 321-332.
34. Canadian Government. (2009). Employment Insurance (EI) and maternity, parental and sickness benefits [website]. http://www.servicecanada.gc.ca/eng/ei/ types/special.shtml. Accessed June 17, 2009.
35. Ministère du Travail du Québec. (2004). Portrait statistique des conventions collectives analysées en 2003 au Québec. Québec: Direction des données sur le travail, Ministère du Travail du Québec.
36. Calhoun, E. A., Chang, C. H., Welshman, E. E., Fishman, D. A., Lurain, J. R., & Bennett, C. L. (2001). Evaluating the total costs of chemotherapy-induced toxicity: Results from a pilot study with ovarian cancer patients. Oncologist, 6(5), 441-445.
37. Ihbe-Heffinger, A., Ehlken, B., Bernard, R., Berger, K., Peschel, C., Eichler, H. G., et al. (2004). The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers. Annals of Oncology, 15(3), 526-536.
38. Moore, K. (1998). Out-of-pocket expenditures of outpatients receiving chemotherapy. Oncology Nursing Forum, 25(9), 1615-1622.
39. O'Brien, B. J., Rusthoven, J., Rocchi, A., Latreille, J., Fine, S., Vandenberg, T., et al. (1993). Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: Survey of five Canadian centres. Canadian Medical Association Journal, 149(3), 296-302.
40. Sculpher, M., Palmer, M. K., & Heyes, A. (2000). Costs incurred by patients undergoing advanced colorectal cancer therapy. A comparison of raltitrexed and fluorouracil plus folinic acid. PharmacoEconomics, 17(4), 361-370.
41. Arozullah, A. M., Calhoun, E. A., Wolf, M., Finley, D. K., Fitzner, K. A., Heckinger, E. A., et al. (2004). The financial burden of cancer: Estimates from a study of insured women with breast cancer. Journal of Supportive Oncology, 2(3), 271-278.
42. Chan, A., Jacobs, P., Yeo, W., Lai, M., Hazlett, C., Mok, T., et al. (2001). The cost of palliative care for hepatocellular carcinoma in Hong Kong. PharmacoEconomics, 19(9), 947-953.
43. Longo, C. J., Fitch, M., Deber, R. B., & Williams, A. P. (2006). Financial and family burden associated with cancer treatment in Ontario, Canada. Supportive Care in Cancer, 14(11), 1077-1085.
44. Schulz, R., Williamson, G. M., Knapp, J. E., Bookwala, J., Lave, J., & Fello, M. (1995). The psychological, social, and economic impact of illness among patients with recurrent cancer. Journal of Psychosocial Oncology, 13(3), 21-45.
45. Sherman, E. J., Pfister, D. G., Ruchlin, H. S., Rubin, D. M., Radzyner, M. H., Kelleher, G. H., et al. (2001). The collection of indirect and nonmedical direct costs (COIN) form: A new tool for collecting the invisible costs of androgen independent prostate carcinoma. Cancer, 91(4), 841-853.
46. Butler, L., Downe-Wamboldt, B., Melanson, P., Coulter, L., Keefe, J., Singleton, J., et al. (2006). Prevalence, correlates, and costs of patients with poor adjustment to mixed cancers. Cancer Nursing, 29(1), 9-16.
47. Gordon, L., Scuffham, P., Hayes, S., & Newman, B. (2007). Exploring the economic impact of breast cancers during the 18 months following diagnosis. PsychoOncology, 16(12), 1130-1139.
48. Grunfeld, E., Coyle, D., Whelan, T., Clinch, J., Reyno, L., Earle, C. C., et al. (2004). Family caregiver burden: Results of a longitudinal study of breast cancer patients and their principal caregivers. Canadian Medical Association Journal, 170(12), 1795-1801.
49. Thorpe, K. E., & Howard, D. (2003). Health insurance and spending among cancer patients. Health Affairs (Suppl Web Exclusives), W3, 189-198.
50. Langa, K. M., Fendrick, A. M., Chernew, M. E., Kabeto, M. U., Paisley, K. L., & Hayman, J. A. (2004). Out-of-pocket healthcare expenditures among older Americans with cancer. Value in Health, 7(2), 186-194.
51. Muller-Nordhorn, J., Bruggenjurgen, B., Bohmig, M., Selim, D., Reich, A., Noesselt, L., et al. (2005). Direct and indirect costs in a prospective cohort of patients with pancreatic cancer. Alimentary Pharmacology & Therapeutics, 22(5), 405-415.
52. Lidgren, M., Wilking, N., Jonsson, B., & Rehnberg, C. (2007). Resource use and costs associated with different states of breast cancer. International Journal of Technology Assessment in Health Care, 23(2), 223-231. (Pubitemid 46642729)
53. Foddy, W. (1993). Constructing questions for interviews and questionnaires. Cambridge: Cambridge University Press.